{
    "clinical_study": {
        "@rank": "83913", 
        "arm_group": {
            "arm_group_label": "Propofol", 
            "arm_group_type": "Experimental", 
            "description": "Propofol dosage titration, comparison of the effect of different concentration of propofol to the myocardial performances, namely at 1.0ng/ml, 2.0ng/ml and 3.0ng/ml."
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is primarily to determine the effects of propofol at different\n      concentration on the mitral valve annulus by using  Tissue Doppler Imaging"
        }, 
        "brief_title": "Propofol Effects on Mitral Valve Annular Velocity", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Valvular Heart Disease", 
            "Coronary Artery Disease"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Coronary Artery Disease", 
                "Myocardial Ischemia", 
                "Coronary Disease", 
                "Heart Diseases", 
                "Heart Valve Diseases"
            ]
        }, 
        "detailed_description": {
            "textblock": "The purpose of this study is to evaluate the effects of different concentration of propofol\n      on patients who are undergoing cardiac surgery. The patients will receive infusion\n      remifentanil 0.5mcg/kg/min with different target-site propofol concentration namely\n      1.0ng/ml, 2.0ng/ml and 3.0ng/ml. Tissue Doppler Imaging by transesophageal echocardiography\n      will be done to assess the changes in cardiac function."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        patients undergoing cardiac surgery\n\n        Exclusion Criteria:\n\n        low ejection fraction < 50% on transthoracic echocardiography atrial fibrillation\n        pacemaker pericardial and infiltrative myocardial disease mitral annular calcification,\n        surgical rings, prosthetic mitral valve lateral left ventricular wall motion abnormality\n        oesophageal abnormality history of extensive radiation to the mediastinum upper\n        gastrointestinal bleeding"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "14", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 22, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01826149", 
            "org_study_id": "20120925"
        }, 
        "intervention": {
            "arm_group_label": "Propofol", 
            "description": "Propofol dosage titration to achieve effect site concnetration 1.0 ng/ml, 2.0 ng/ml and 3.0 ng/ml using target controlled infusion", 
            "intervention_name": "propofol", 
            "intervention_type": "Drug", 
            "other_name": "Fresofol (2% propofol, Fresinius Kabi)"
        }, 
        "intervention_browse": {
            "mesh_term": "Propofol"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "August 28, 2013", 
        "location": {
            "contact": {
                "email": "pondkim@unitel.co.kr", 
                "last_name": "Tae-yop Kim, M.D, PhD"
            }, 
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of", 
                    "zip": "143-729"
                }, 
                "name": "Konkuk University Medical Center"
            }, 
            "investigator": [
                {
                    "last_name": "Tae-Yop Kim, MD PhD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Jeongho Seok, MD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "1", 
        "official_title": "The Effect of Propofol on Tissue Doppler Imaging of Mitral Valve Annular Velocity During Remifentanil-based Cardiac Anesthesia", 
        "overall_contact": {
            "email": "pondkim@unitel.co.kr", 
            "last_name": "Tae-Yop Kim, M.D, PhD"
        }, 
        "overall_official": {
            "affiliation": "Konkuk University Medical Center, Seoul, Korea, Republic of", 
            "last_name": "Tae-yop Kim, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Korea: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "November 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "To examine the effect of Propofol at different effect-site concentration ( 1.0 ng/ml, 2.0 ng/ml and 3.0 ng/ml) on S'  (systolic mitral valve annular velocity) during remifentanil-based anesthesia.", 
            "measure": "Change of systolic mitral valve annular velocity (S')", 
            "safety_issue": "No", 
            "time_frame": "10 min after achieving 3 different propofol concentrations"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01826149"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Konkuk University Medical Center", 
            "investigator_full_name": "Tae-Yop Kim, MD PhD", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Early diastolic mitral valve annular velocity (e')", 
                "safety_issue": "No", 
                "time_frame": "10 min after achieving 3 different propofol concentrations"
            }, 
            {
                "measure": "late diastolic (atrial contractile) mitral valve annular velocity (a')", 
                "safety_issue": "No", 
                "time_frame": "10 min after achieving 3 different propofol concentrations"
            }, 
            {
                "measure": "ejection fraction", 
                "safety_issue": "No", 
                "time_frame": "10 min after achieving 3 different propofol concentrations"
            }, 
            {
                "measure": "phenylephrine infusion rate", 
                "safety_issue": "No", 
                "time_frame": "10 min after achieving 3 different propofol concentrations"
            }
        ], 
        "source": "Konkuk University Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Konkuk University Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "August 2013"
    }
}